Filter by: Open opportunities | Closed opportunities
i4i Connect - February 2025
open-opportunity“The NIHR Invention for Innovation (i4i) programme is accepting outline applications to their latest researcher-led Connect funding opportunity.”
Tara Copps
Programme Assistant
Connect is a researcher-led funding opportunity and supports small to medium-sized enterprises (SMEs) in need of a funding boost to reach the next stage in the technology development pathway.
This is a two-stage funding opportunity. To apply for the first stage, you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
Women TechEU
open-opportunity“A two-year EU-funded project funding and supporting women leading deep tech start-up companies from Europe. A total of 160 winner start-ups will receive €75k in non-dilutive grants as well as a personalised business development programme including mentoring, coaching and training.”
Ben Hugill
Innovation Advisor
The Women TechEU project is on a mission to ignite the potential of women-led early-stage start-ups in deep tech. 160 talented women entrepreneurs from across the European Union and Horizon Europe associated countries will be receiving direct support. With 75k€ grant (non-diluting finance) and a personalised business development programme, the project will be paving the way for these innovators to shine as leaders in deep tech innovation across Europe.
NIHR: Decarbonising the health and social care system
open-opportunity“NIHR is interested in building research capacity and generating high-quality research evidence to develop and evaluate innovations focused on the decarbonisation of the health and social care system. This cross-programme funding opportunity is part of the commitment to helping the health and social care system become more sustainable and reach net zero status.”
Cheryl Scott
Industry and Innovation Lead
NIHR are looking to fund research into decarbonising the health and social care system. As part of their climate health and sustainability commitments to help reduce carbon emissions and achieve net zero, this cross-programme funding opportunity will run annually for the next 5 years. There will be £25 million total funding available across the 5 years, with a new application process opening each year.
EIC Accelerator
open-opportunity“EIC Accelerator is a funding programme great for innovators that have the ambition and commitment to scale up, and are looking for substantial funding, but the risks involved are too high for private investors alone to invest.”
Alex Leach
Deputy Director of Programmes
EIC Accelerator develops and helps to scale up innovations with the potential to create or disrupt markets. Single start-ups and SMEs, individuals intending to launch a SME and small mid-caps can apply.
The Life Sciences Innovative Manufacturing Fund (LSIMF)
open-opportunity“The objective of the fund is to increase UK health resilience by strengthening the UK’s manufacturing capacity and capability. LSIMF define health resilience as the UK’s ability to withstand and recover from health emergencies such as pandemics, long-term healthcare challenges and supply chain disruption.”
Alex Leach
Deputy Director of Programmes
The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to build resilience for future health emergencies and capitalise on the UK’s world-leading research and development capabilities. The fund will enhance and accelerate affordable access to mature, new and emerging Life Sciences products for both pandemic and non-pandemic scenarios.
NIHR i4i Product Development Awards
open-opportunity“This funding call provides an excellent opportunity for innovators to continue their development by helping to de-risk the next step. If you’re interested in applying for any of the funding streams or would like to discuss opportunities further, then please get in touch with the team.”
Ben Hugill
Innovation Advisor
i4i Product Development Awards (PDA) support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care system.
